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THE CAUSAL MOSAIC UNDER CONSTRUCTION:
THE EXAMPLE OF EXPOSOMICS
24.1 Making mosaics
A mosaic is an assembly of tiny tiles, all different. When the tiles are carefully com-
posed, positioned and angled, they will make a figure. They can be tiny personal pieces
of craft, or vast and stunning public pieces of art, such as the mosaic on the ceiling of
the Basilica di San Marco in Venice. In either case, every tile contributes to making the
whole mosaic. In this book we have provided the materials to make a causal mosaic, to
arrange and rearrange the different accounts of causality.
The accounts of causality. The accounts of causality developed in the literature are the
tiles of any mosaic. They are descibed in Part 2, and there are plenty to choose from,
stretching from counterfactuals and agency, to physical process, or INUS conditions. In
chapter 1 we explained the five scientific problems of causality: explanation, prediction,
control, inference and reasoning. We assessed all of the accounts of causality according
to whether they do or do not help with one or more of the five scientific problems. It
seems that no one account addresses all five problems successfully. Right from the start,
we abandoned the idea that one account will on its own provide a full-blown causal
theory, allowing us to do everything we might need to do, for all scientific domains.
Instead, the various accounts—the tiles—each do something valuable.
The five philosophical questions. Part 3 examined different ways in which the tiles—
the accounts—can be arranged, according to different perspectives or interests. In chap-
ter 22 we explained the five philosophical questions: epistemology, metaphysics, me-
thodology, semantics, and use. We saw the resulting philosophical theory fragments
constructed as answers to these questions. We explained why it is important to clarify
the scope of the question asked, to understand what purposes the different accounts of
causality serve, to see how they can be used together. One tile may be better placed in
epistemology, and another in metaphysics; or the same tile may need to be used in dif-
ferent ways to address different questions. This means that many of the Part 2 accounts
can be seen as complementary, addressing different questions, rather than as competing
answers to a single question. If we are clear about what question we are asking, it is
more likely that we will find complementary notions, from the other fragments, to help
us complete our account, and solve our problem or problems. This accords with the idea
that the philosophical questions, and the theory fragments built in response to them, are
distinct but not independent.
Diversity and pluralism. The idea of using the different accounts in a complementary
way may sound good, but it is not simple. In chapter 23 of Part 4 we explained some
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of the challenges for recomposing the accounts of causality—challenges for making a
mosaic out of these materials. These were the challenges of diversity and pluralism.
Worldly causes seem to be very different, we have different sources of evidence, and
the methods of the sciences are pretty diverse. What form of pluralism suits a given
scientific context is at least partly an empirical question. We need to study the field, its
particular problems and methods, and work out what tiles and what fragments we need,
so that we can start to build up a mosaic.
The brief recap on accounts (tiles), questions (fragments) and diversity serves as a re-
minder that there are a lot of materials available in the literature on causality. So how
do we put them together? Most of the accounts address more than one of the five sci-
entific problems, and most can address more than one of the five philosophical ques-
tions. Further, the different accounts—the tiles—also interrelate. For example, some of
them form into the difference-making or dependence family, others into the production
family. Alternatively, some are primarily conceptual, some primarily epistemological
or methodological—or single accounts have alternative conceptual or methodological
interpretations.
This is why we illustrate how we think this complex philosophical literature can be
used by scientists and others trying to think about causality with the idea of making
a mosaic, because a mosaic is precisely a whole made out of diverse pieces. We ac-
knowledge a debt to Carl Craver’s useful metaphor in writing of the ‘mosaic unity of
neuroscience’ in Craver (2007). Russo (2009) also talks about the ‘mosaic of causality’,
of which the epistemology of causal modelling is but one tile. In this chapter we extend
these useful metaphors and link them to both philosophical and scientific practice. We
will demonstrate how the exercise can be done, using the example for exposomics, an
emerging field of science that we will explain. Note that we do not think we are giving
the final answer for exposomics, nor for the philosophy of causality—we suggest just
one useful arrangement of the tiles for exposomics.
24.2 Preparing materials for the exposomics mosaic
Exposomics, or the science of exposure
Exposomics, or the science of exposure, is an emerging area of research in the biomed-
ical field. It draws on biology, epidemiology, environmental science, statistics, bioin-
formatics, and information and communication technologies (ICTs). The field is new,
proposing innovative and challenging methods to study exposure to environmental fac-
tors and their effects on several diseases. Exposomics faces many challenges at the con-
ceptual and methodological level and also in making policy recommendations. The hope
is that interactions between exposomics scientists and Causality in the Sciences (CitS)
philosophers will help address these challenges.36
36At the time of writing, there is a major FP7 project studying environmental exposure and its effects on
several diseases: http://www.exposomicsproject.eu. The project is coordinated by Prof. Paolo Vineis
at Imperial College, London. We are extremely grateful to Prof. Vineis and collaborators for the opportunity
to work and discuss with them.
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To understand what exposomics science tries to achieve, we need to take one step
back to more traditional studies on environmental exposure and disease. This has been
done by epidemiologists, who study the distribution and variation of exposure and dis-
ease in populations. Traditional epidemiology, and more precisely environmental epi-
demiology, managed to establish links between environmental factors and classes of
diseases. They found strong and stable correlations between categories of factors (such
as air pollution, chemicals, etc.) and diseases (such as cancer, allergies, etc.). How ex-
actly environmental factors lead to disease is much less understood and the methods
used so far will not illuminate that question. This calls for a turn in the methods used in
epidemiology, which is precisely what is happening in exposomics. Scientists think that
we need to study exposure and disease at the molecular level, in order to understand the
molecular basis of life and disease.
To do this, the question of the connection between exposure and disease has to be
translated to the molecular level: How to track changes at the micro-molecular level
due to levels of chemicals in, for example, air or water? The answer to this question
lies, according to exposomic scientists, in the study of biomarkers. ‘Biomarker’ means
biological marker. A biomarker is a characteristic which is objectively measured and
which indicates normal biological processes, or pathogenic processes, or a pharmaco-
logic reaction to a therapeutic intervention. Where do we look for those markers? There
are various candidates, for instance metabolites in blood, proteins, or features of gene
expression. These can be detected and measured, and so tell us something about what’s
going on in the body.
Carrying on the study of exposure and disease at the molecular level is, in a sense,
the effect of a much bigger change—a change in the concept of exposure. One aspect of
exposure is familiar to us: there is stuff ‘out there’ we have contact with and to which
our body responds in some way. Exposomic scientists call this the ‘external exposome’.
A second aspect of exposure is the novelty in the approach: there is stuff that happens
inside the body, once we have contact with the stuff out there. But what happens in-
side depends not just on the stuff out there, but also on the internal environment that
our body creates. Exposomics scientists call this the ‘internal exposome’. Now, to un-
derstand how, say, pollution leads to allergies, we need to understand both aspects: the
internal and the external, i.e. the total, exposome (Wild, 2005; Wild, 2009; Wild, 2011;
Rappaport and Smith, 2010).
In practice, how can we study the internal and the external exposome? For the ex-
ternal, that is relatively easy, provided that we can make accurate measurements of the
environmental factors. The internal is more complicated, and this is where new statisti-
cal methods and new technologies come to the rescue.
After exposure, scientists need to collect bio-samples and analyse them, looking for
relevant biomarkers of exposure. But what biomarkers? That is precisely the problem.
Exposomics is seeking help from biological theory and at the same time is helping
refine biological theory (Vineis and Chadeau-Hyam, 2011). Exposomic scientists also
look for biomarkers that indicate the presence of a disease. And finally they look for the
biomarkers that are in between, the biomarkers that indicate that some clinical change
within the body has occurred or is occurring. Exposomics scientists are creating new
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cohorts (i.e. groups of people) to carry out these studies, and are also using data available
from previous studies, such as the EPIC cohort (European Prospective Investigation into
Cancer and Nutrition).
Once the data are in, the issue is how to analyze them. This is where a novel
‘meeting-in-the-middle’ methodology enters the scene. Exposomic scientists try to match
the biomarkers that are most correlated with the exposure, with those that are most cor-
related with the disease, hoping to find a sensible overlap—in the middle—and also
hit on those biomarkers that may indicate early clinical changes, the very first indica-
tors of the onset of disease. This requires highly sophisticated statistical modelling and
network theory approaches.
But why are exposomics scientists bothering with all this? Well, in a sense this is
a response to genomics. Studies of the genome achieved a lot, but still less than what
was hoped for (Manolio et al., 2009). In particular, we hoped to gain much more insight
about disease mechanisms than we actually did. Exposomics scientists are trying a new
venture, in quite a difficult field. If, as it seems, disease is not all in our genes, we need
to study how our body interacts and reacts to stuff that may well be responsible for a
number of diseases. This is the line of argument of exposomics scientists, who have
been quite successful in gaining the support of European funding bodies. The hope is
to get a much deeper understanding of disease mechanisms and also to advise policy
makers about public health matters.
This gives a quick overview of what exposomics science is, what its aims are, and its
position with respect to traditional epidemiology and to genomics. We will now see in
some more detail what scientific problems are at stake. In this chapter we illustrate the
CitS approach by showing how some of the different concepts and methods discussed
in Part 2 play a role in a scientific project dealing with many causal issues. Exposomics
enables us to touch simultaneously on epistemological, methodological, and metaphys-
ical issues, and also on issues concerning how we use causal knowledge. It also helps
us show how the distinction between difference-making and production can be useful,
how probabilistic and variational issues come into play, and so on.
Our aim here is to illustrate how the resources we have laid out in the book can
be marshalled to help think about the issues. We lay this out as a series of questions
to address. Precisely because these questions will have different answers for different
purposes, different people might find different tiles more useful. This is why we think
having a guide to them all is helpful. We make no suggestion that the illustration we pro-
vide here is unique. It is also a timely philosophy. Exposomics is research-in-progress.
In a few years, the situation will have changed and the mosaic of causal concepts useful
to thinking about it may well also have changed. Here we show how to do the exercise;
we don’t say that this is the one mosaic for exposomics, nor the one mosaic for science
looking for causes more generally. Since this is one of the cases we both work on, this
means we also give hints about what we think would be exciting research to do in the
CitS spirit. We are carrying out some of these projects ourselves, but there is so much
going on that we hope many other people join the venture.
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Question 1: What scientific problems would it be useful to address?
Thinking through the five scientific problems of causality can help identify distinct is-
sues for any scientific case. What are the scientists trying to do? Is there more than one
aim, and do they conflict?
Inference. Is there a causal relation between X and Y? Does X cause Y? What are the
causes of Y? How much of X causes how much of Y?
Basically, causal inference concerns finding out about causes. In exposomics, we
want to know what the environmental causes of disease are. We want to find links
between environmental factors and diseases. We also want to establish links between
exposure and some biomarkers and diseases and some biomarkers, so that ultimately
we can link up the whole chain from environmental exposure to disease. We need to
think about how we can establish such correlations. Where can we get the data? (For
exposomics, technologies help a lot, but produce big data sets, which are their own
challenge.)
Explanation. How do we (causally) explain phenomena? To what extent is a phe-
nomenon explained by statistical analyses? What level of explanation is appropriate for
different audiences, such as fellow specialists, the public, or jurors in a court?
We often want to know not just what happened or will happen, but how it happened,
and why. This is causal explanation. In exposomics, the explanations offered by our
background knowledge are very important. We are trying to probe an area where little
is known, but we depend very heavily on what we already know about the human body,
and about environmental causes of disease, found in traditional epidemiology. A lot
of our knowledge of the body takes the form of known mechanisms, which explain,
for example, how cells make proteins, and how our immune system works. This is
important to help us make sense of the many correlations we will find in big data sets.
Just correlations won’t do. We need a plausible biochemical story of what happens after
exposure and inside the body, to think we are starting to make progress on understanding
disease causation by environmental factors—at the molecular level.
Prediction. What will happen next, and how do we find out what will happen next?
How accurate are our predictions about the evolution of some population characteristics
(e.g. mortality, morbidity, . . . )? What does a physical theory predict will happen in a
given experimental setting?
Prediction is just working out what will happen. In exposomics, we want to know
things like what will happen to populations if current levels of environmental contami-
nants remain the same, or continue to rise. We also want to know whether we can predict
disease given knowledge of biomarkers. If we can better predict disease trends, thanks
to biomarkers, this will help us decide what public health actions we should take.
Control. How do we control variables that may confound a relation between two other
variables? In what cases is it appropriate to control for confounders? How do we con-
trol the world or an experimental setting? How do we find out about that? This extends
all the way from interfering with a system to get a slightly different result, to the con-
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struction of entirely new causal systems, such as smart phones, or GPS, or a political
system.
Control is going beyond prediction, to alter what will happen. In exposomics, our
core concern is how to prevent disease. But we also want to know how we can un-
derstand the pathways from exposure to disease, and thus better control possible con-
founders, and get a ‘cleaner’ link or pathway from exposure to disease.
Reasoning. What reasoning underlies the construction and evaluation of scientific
models? What conceptualization of causation underpins causal methods? How do we
reason about all aspects of causality? How can we sharpen up that reasoning, making it
more precise and so more effective?
Causal reasoning is our broadest scientific problem, as it concerns all the ways we
think about causality in science, explicitly and implicitly. In exposomics, we need to
think in terms of causes that hard to find and that are fragile, i.e. whose actions or ca-
pacities are easy to disrupt. We need to adjust our rationale for our methods accordingly,
because looking only for correlations isn’t enough, and we don’t have a well-developed
theory of the causation of disease by interactions of genes and environmental factors
within the body to help us much either. How should we model the interrelations be-
tween biomarkers?
Note that under causal reasoning is where we worry about relations between the
other four problems. In exposomics, we have to think about what existing explanations
are available, and what causal inference methods are available, decide how they fall
short, and design the methods of the project to meet the needs of the current state of
the science. It is here that it becomes useful to ask the most obviously philosophical
questions, the conceptual questions. For exposomics, it is useful to wonder: how can we
conceptualize the link from exposure to disease? How does the macro-environmental
level connect to the micro-molecular level? How am I thinking about causality, so that
these links and connections make sense? Does that thinking about causality accord with
my methods?
Question 2: What do the scientists want to know or do, and what problems of diversity
do they face?
As we explained in chapter 22, philosophical work on causality in the spirit of CitS
can begin at any point, from science or from philosophy. So we offer these questions
merely as an illustration of how one might choose to approach a scientific case study.
This question is useful to ask, to get a sense of the scope of the research you are looking
at, and the scale of the problem understanding it poses.
Fragility. In exposomics, scientists are looking for fragile relations, relations which
disappear in some contexts. This problem is important to exposomics, but also af-
fects every field where populations are heterogenous, where complex mechanisms exist,
where there are homeostatic mechanisms that change and adapt in response to multiple
stimuli, and so on. So the question is: how do we isolate such fragile relations? How
can we establish that they are causal given their fragility? What are the right methods to
circumscribe them? Experiments? Observations? Simulations? What?
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Diverse research groups. Exposomics science is not the result of one single brain.
Research groups are essential. Exposomics projects usually involve consortia of several
institutions, and within each institution there are several groups (epidemiologists, statis-
ticians, etc.). But this is not unique to exposomics. Another example is the discovery of
the Higgs boson, which has been possible thanks to numerous research groups working
on different experiments. Much of current research needs synergies between different
groups and approaches.
Diverse fields of science. Exposomics is (molecular) epidemiology, but it is also medici-
ne, and biomedicine, and biochemical medicine, and medicine using knowledge from
nuclear physics, and from statistics, and from sociology etc. Understanding, predicting
and preventing disease is a complex enterprise where each of these fields contributes
something vital. Again, this is not a problem only for exposomics, but is a feature of
many important collaborations nowadays.
Diverse technologies. The embeddedness of technology in modern medicine goes far
beyond looking through a microscope. We don’t ‘see better’ using omics technology;
we collect data about stuff that we wouldn’t see at all otherwise! Actually, we don’t ‘see’
even using these technologies. We are able to identify signals that then need to be in-
terpreted in order to find something in there. The technologies used to generate, collect,
and analyse data in exposomics (GPS and sensors, omics technologies, network-based
statistics software, etc.) change the landscape of what we can observe and study and of
how we understand and conceptualize diseases. How should we conceive of the relation
between science and technology in the face of techno-science? What questions does
technology pose for the practice and use of medicine? Again, this does not only arise in
exposomics. Think for instance of diagnostic tools, that allow us to see possible tumours
very early and intervene. While this is generally seen as an achievement and is praised,
some controversies are also arising, for instance the ‘slow medicine’ movements.37 New
technological tools have the power to enhance the production and analysis of data, and
also to ‘create’ new phenomena, by making diseases appear too early or even when they
are merely a possibility. How we should react in response to these technological tools
is quite a difficult issue: think about Angelina Jolie undergoing mastectomy to avoid
cancer development. Is this ethical? Is this action justified by the evidence available?
Data overload. Big data is a problem for exposomics, as for many other sciences.
Having a lot of data, massive datasets, is not a solution per se. Big data creates a big
problem of analyzing data, of using them, or re-using them for other research questions.
In exposomics, for instance, they are re-using samples and data from other cohorts.
Maintaining their quality is a serious challenge (Leonelli, 2009; Leonelli, 2014; Illari
and Floridi, 2014).
Significant diversity in evidence and data probing methods. One idea in exposomics
is that to establish how pollutants induce changes in the body at the molecular level we
37See e.g. http://blogs.bmj.com/bmj/2012/12/17/richard-smith-the-case-for-slow-medicine/,
accessed 23rd July 2013, and McCullough (2009), who initiated the “Slow Medicine” movement.
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use different methods: analyse the exposure (chemistry tools), analyse samples (again
chemistry and nuclear physics and omics tools, etc.), analyse data with statistics and
other similar tools (e.g. network theory, calibration methods etc.). Another idea is that
data should be available for re-analysis by different people with different tools. Making
all this work effectively can be ferociously difficult, and also touches on political issues
about accessibility of data, who funds research, who owns the data, and so on.
Clearly there are some significant challenges of diversity in understanding exposomics.
Question 3: What philosophical questions would it be useful to address?
Asking the five philosophical questions can be a useful way to push beyond the sur-
face, to uncover assumptions that may be underlying the research methodologies or
questions.
Epistemological issues. What do the Exposomics scientists want to know? What kinds
of assumptions about scientific knowledge might they be making? Would the assump-
tions they are making have a more general bearing on causal epistemology?
Exposomics scientists want to understand how environmental exposure is linked to
disease. In that sense, their epistemological question is fairly simple. But answering it
is rendered complex by surrounding knowledge. They know a lot about the system, and
so many mechanisms within the body are assumed, as are some known mechanisms for
environmental causes of disease, such as radiation damaging DNA, and DNA methyla-
tion due to smoking. But a lot is still unknown, and in the middle of that exposomics
scientists are looking for many small causes, with small effects, and large interaction ef-
fects. They expect widely different factors to be causes, including e.g. social and chem-
ical factors. Their use of new omics technologies allows a comprehensive approach,
but generates vast amounts of data that must all be stored, maintained, and processed.
Naturally, this is strongly linked to the scientific problem of causal inference. But ex-
posomics is also a fascinating lesson in how increasing knowledge happens in such a
complicated way, particularly when we are taking the first tentative steps in an attempt
to push back the current boundaries of knowledge.
Metaphysical issues. Are there assumptions about the nature of the domain being in-
vestigated? What are scientists assuming about the causal relations they are seeking?
In exposomics, there are certainly assumptions, based on known mechanisms de-
scribed above. Nevertheless, scientists assume that there is something to track in the
middle of the vast uncharted territory, whereby particular environmental factors cause
disease. Even though it can be hard to get such factors to show up—hard to find the
fragile correlations, in the middle of the many misleading correlations likely to exist in
large datasets—they assume the causes are there, and can be found. They are interested
in how to characterize them.
Methodological issues. What methodology or methodologies are being used? What do
the scientists say about why they chose as they did? Are they using a novel methodol-
ogy? What are the background assumptions of any models or other standard techniques?
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As a reaction to the novel methodological challenges of exposomics, the scientists
have articulated a new ‘meeting-in-the-middle’ methodology. Broadly, they are trying
to track biomarkers of exposure, and biomarkers of early disease onset, and match up
biomarkers that correlate with both in the middle, so that ultimately they can track the
entire evolution of disease using biomarkers. This new methodology raises interesting
issues about the relations between background knowledge and new causal discoveries.
What makes us think that the meeting-in-the-middle methodology and use of omics
technologies will really advance understanding of disease mechanisms? How do we—
and funders—know that this is not mere hype?
Semantic issues. Do the scientists seem to be using causal language in a standard way?
Are they innovating? How? What does it mean that macro-environmental factors cause
micro-molecular changes in the body? What kind of worldly causation would that be?
The main reason we are personally so drawn to studying exposomics is that the
scientists do seem to be innovating. They have explicitly created a new word, the ‘expo-
some’, by analogy with the ‘genome’ to capture the system-wide nature of the interac-
tions they expect to see. They are then trying to think about causality from within the ex-
posome, while simultaneously struggling with some serious methodological challenges.
One thing they do, when talking about causality, is frequently talk about signalling. Do
they think this has something to do with the meaning of causality? Is it a way to point
to one notion that could cash out causality (see below) or is it a way of avoiding causal
talk (like sometimes using the language of determinants instead of causes in biomedical
sciences)?
Issues of use. What are the scientists intending to use their results for? What are other
people intending to use their results for? How can results be communicated to research
funders and policy makers so that actions can be taken? How can the public use the
results? How is fine-grained molecular knowledge of disease mechanisms going to be
used for policy purposes?
Clearly the work is ultimately intended to inform healthcare recommendations. But
it is not obvious how to use exposomics results for policy. For instance, if exposomics
results mainly concern relations at the molecular level, how can we inform governments
about interventions at a social level, i.e. trying to change patterns of behaviour, or ban-
ning certain kinds of pollutants? How do results about ‘molecules’ translate into actions
about ‘people’ and ‘behaviours’?
Again, asking all these questions about a domain of science is an interesting study,
and helps us to explore aspects of the work that may otherwise not occur to us. We
have argued in chapter 22 that these questions cannot be addressed wholly in isolation.
Nevertheless, addressing them all simultaneously is a lot of work. We also suggested
that we have to identify which question or questions are of most interest to us, in light
of our goals and interests, and keep that question or questions clear in our work.
24.3 Building the exposomics mosaic
We are now in a position to begin building the mosaic itself, beginning by selecting the
tiles for the mosaic.
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Question 4: What accounts might be useful?
Which of the five scientific problems are most of interest to us? The summary tables of
appendix A can be used to identify accounts that might be useful on that basis. Which
of the theory fragments do we want to concentrate on? We can use the summary table,
and the examples, ‘Core ideas’ and ‘Distinctions and warnings’ of each Part 2 chapter to
track down accounts that touch on the scientific problems and philosophical questions
we have identified. We selected the following tiles to help us with our thinking about
exposomics:
Levels. The ‘exposome’ is a new (causal) concept put forward by epidemiologists in
order to redefine the causal context in which causal relations at different levels take
place, so chapter 5 on levels of causation may be useful. The issue of the levels here
concerns more than the relation between the generic and the single-case level. It also
concerns the integration of factors of different natures (social and biological) into the
same explanatory framework. So, what understanding of ‘levels’ helps illuminate con-
cerns in exposomics science?
Evidence. In this study the interplay between evidence of difference-making and ev-
idence of mechanisms is crucial to establish causal relations successfully, so chapter 6
could be interesting. Biomarkers of disease are supposed to make a difference to the
probability of disease, but this probability raising needs to be substantiated by a plausi-
ble underlying mechanism. How are the scientists searching for each?
Production-mechanisms. Exposomics scientists talk about mechanisms, examined in
chapter 12, and clearly know a lot about mechanisms such as biochemical mechanisms
in the cell and mechanisms such as the immune system in the body. How are they think-
ing about these things? Note that exposomics scientists also conceptualize the evolution
of biomarkers as a process, so how should we think about this with respect to the dis-
tinction between difference-making and mechanisms? Is ‘mechanism’ the right way to
think about causal linking in exposomics?
Production-information. As well as talking about processes, exposomic scientists talk
about ‘signal detection’. Since they are looking for something underlying their data, a
kind of linking, it looks like they are seeking productive causality, and they associate
this idea with the idea of picking up signals. So it looks like productive causality, in the
minds of exposomics scientists, is associated with the concept of information, discussed
in chapter 13. So, information, as a production account, should be investigated. Would
it suit exposomics? Why? Could it help solve problems elsewhere too?
Capacity. What does it mean that pollutants have the capacity to induce changes in the
body at the molecular level? How can we find out exactly what this capacity is? When
it is activated, what is its threshold to induce changes? Also, is the predictive power of
a biomarker due to its own capacity, or to the capacity of some entity it is a proxy for?
Here, the examination of capacities in chapter 14 is of interest, particularly the idea of
masking of capacities and the resulting difficulty of getting evidence of capacities when
they are sensitive to context.
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Depending on what you want to know, and what you already know, there could be
material in many other chapters that is useful to you. For example, a background grasp
of probabilistic approaches to causality is given in chapter 8; more about what powerful
techniques are available for probing data can be found in chapter 7; and a discussion of
how diverse sources of evidence might be thought of as contributing to causal inferences
is available in chapter 18.
Question 5: How can we put together these resources to help us in our thinking?
Philosophical concepts can’t make science easy—nothing can do that. What these ac-
counts of causality can do is to sharpen up thinking. This in turn can help the actual
practice, already being done, to be done with more clarity, aiding communication among
scientists themselves, and outside science and academia more generally.
Now we have accumulated the resources available, we really have to begin choosing
tiles for our mosaic, according to which questions are of most interest to our project.
Exposomics is such a rich case study that there are many questions of both scientific
and philosophical interest. We will just have to pick some to illustrate the process of
building a mosaic. Suppose we take the process of discovery as of primary interest, at
least to start with. Suppose we are interested in how the conceptualisation of causes
can help with the struggle to build a new methodology apt for exposomics. Then we’re
interested in the methodological challenges. We are interested in how semantics and
metaphysics (philosophical questions) might help with constructing a novel methodol-
ogy (philosophical question and scientific problem) for this case of exposomics. In turn,
of course we are interested in how the construction of that novel methodology might
inform semantic and metaphysical questions.
We can use Part 2 chapters, beginning with the core ideas and distinctions and warn-
ings, as guides to place the tiles we have identified in our mosaic:
Levels resources. We can watch out for mistakes translating between the philosophical
and scientific literatures. Inference between the population level and the single case level
is frequently a problem, and we can be alert for mistakes. Often, we can have evidence
of one level, and want to know about the other, but be unable to make the inference
directly. There are also concerns about different kinds of measurements, integrating
them into single model or single explanation, and so on.
Difference-making. This helps us see the difference between worrying about the rela-
tion between cause and effect variables, in isolation from worrying about what happens
in between. In exposomics, as in any other case which generates a large dataset, there
is a problem with finding too many correlations, and requiring some means of isolating
those of interest.
Mechanisms. The idea of entities and activities organized to produce a phenomenon,
initially in an attempt to explain the phenomenon, might be of interest. Can activities
and entities and their organization be found? Can evidence of such things help us? Can
they help answer philosophical questions? Can they help with the scientific problems?
The problems with mechanisms, properly understanding their context and organization,
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do seem to arise here. Context shifts make activities and entities difficult to detect in
exposomics, and the organization of many mechanisms here are so complex we are not
even sure how to begin describing them.
Information. This might offer an interesting way to conceptualize linking in expo-
somics. Partly, it is interesting that a causal link could be something so thin, so ap-
parently intangible. From the problems discussed in chapter 13, we might be wary
that thinking of the link as informational might not be so very informative. On the
other hand, it is reasonable to think of information as something that can work with the
methodology of exposomics—detect at point x, detect at point y, detect at point z, match
up the chain, infer that there’s a link right through the system.
Capacities. These help conceptualize something that is stable, at a particular locality,
in a particular context. Capacities are useful if you can find them. But they are only
useful if they can be found, in spite of context shifts, or if they are stable enough that they
only change with known context shifts. What are the known capacities in exposomics?
What are their limits?
What we end up with is a mosaic, a picture depicting the methodological problems faced
by exposomics scientists, where the tiles of the mosaic have given us the language to
express these problems very clearly, yielding a deep understanding of them. We can say
how these factors relate, how known mechanisms and capacities structure the problem
of exposomics, giving us the background knowledge against which much finer-grained
causal links are sought. In this way we can clear the ground, to show the importance
of the construal of some kind of linking to causal reasoning, and so to addressing the
methodological problems in exposomics. In view of the innovation within the science,
and the absence of existing language in the philosophical debate, it can now be no
surprise that the scientists are reaching for new language to express this. Here philo-
sophical work can feed directly back into the scientific enterprise by helping provide
new concepts, designing a conceptual apparatus that can help support the science.
Note that we are not attempting to say how to write a philosophical paper, but to
indicate how to use the philosophical literature on causality to understand a scientific
problem and to address it philosophically. This, however, is what it is to do philosophy
of science in the CitS style. Our hope is that in creating your own mosaic from the
materials we have provided in this book, you end up with something adapted to your
questions, your problems, allowing you to move forward with them, and communicate
them to others to get any help you need. Not the least of your achievement is to have
identified and refined your questions and problems.
How many mosaics?
There could be indefinitely many such mosaics. If we choose different questions as
our starting-point then, consequently, we collect different tiles, focus on different philo-
sophical questions, and design a different mosaic. Philosophers with different back-
grounds might naturally start from a different perspective, focusing on different ques-
tions from each other. Likewise, scientists with different backgrounds may approach the
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same problem differently. And, clearly, philosophers have taken a different perspective
on causality, by focusing on different questions than scientists usually do.
This kind of mosaic might be useful to build not just for a single person—whether
philosopher or scientist—but for a research group. For example, exposomics researchers
benefit from building a common mosaic, to make their language more precise, and facil-
itate their communication, and their training of postdocs and doctoral researchers. This
‘mosaic of brains’ has been discussed in the literature as ‘distributed understanding’
(Leonelli, 2014), and also using resources from social epistemology, such as Andersen
and Wagenknecht (2013), Fagan (2012), and Beaver (2001).
The mosaic, and the understanding of exposomics science that we have developed
along with it, is something we have made. This does not mean that there is no real-
ity out there. There is. Reality, to echo Floridi (2008), is a resource for knowledge
and we interact with that reality in various ways: using evidence-gathering methods
through epistemological notions. We don’t merely passively imitate, which sometimes
seems to be all that is meant by ‘represent’, causal relations. It takes work to construct
our knowledge about causal relations, gathering data, probing the data using advanced
methods—and then of course using that knowledge to build things, like social or health
policies, which in turn generate more causal knowledge. All this is very active, not at
all passive. Exposomics science shows even more detail. We know there is something
there, something important to us, but it is very difficult to find. We construct technol-
ogy, construct research teams, control circumstances so that what we want to find is
discoverable. Even after that, data processing is still necessary to find anything. There
is a reality out there that we can hit and act upon, study, model and understand, using
biomarkers, or conceptualizing disease causation using processes or other notions. But
we have to interfere a great deal with the system and constantly design or re-design con-
cepts in order to find out. Ultimately we get causal knowledge by a very sophisticated
interaction between us and the world, using reality as a resource to construct our causal
knowledge.
To conclude, in this chapter, as in the book generally, we have focused on explain-
ing the philosophical literature on causality to people outwith that literature. From that
point of view, we have used this chapter to illustrate how anyone can use the resources
of the causality literature to think better about science. But, particularly in Part 3, we
also examined issues about how philosophy can successfully engage with science. This
chapter can also be read as the finale to chapters 20 and 22, by showing in an extended
way how science can be a rich resource for the development of philosophical problems.
